Literature DB >> 18838582

Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns.

A Waléria-Aleixo1, A N Martins, M B Arruda, R M Brindeiro, R M Da-Silva, F F Nobre, D B Greco, A Tanuri.   

Abstract

The major human immunodeficiency virus type 1 subtype circulating in Brazil is B, followed by F and C. We have genotyped 882 samples from Brazilian patients for whom highly active antiretroviral therapy failed, and we found subtype B and the unique recombinant B/F1 forms circulating. Due to codon usage variation, there is a significantly lower incidence of the substitutions L210W, Q151M, and F116Y in subtype F1 isolates than in the subtype B counterparts.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18838582      PMCID： PMC2592894          DOI： 10.1128/AAC.00820-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  37 in total

1.  Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay.

Authors:  G Carrion; L Eyzaguirre; S M Montano; V Laguna-Torres; M Serra; N Aguayo; M M Avila; D Ruchansky; M A Pando; Jose Vinoles; J Perez; A Barboza; G Chauca; A Romero; A Galeano; P J Blair; M Weissenbacher; D L Birx; J L Sanchez; J G Olson; J K Carr
Journal:  AIDS Res Hum Retroviruses       Date:  2004-09       Impact factor: 2.205

2.  Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G.

Authors:  Ana Barroso Abecasis; Koen Deforche; Joke Snoeck; Lee T Bacheler; Paula McKenna; Ana Patrícia Carvalho; Perpétua Gomes; Ricardo Jorge Camacho; Anne-Mieke Vandamme
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

3.  An automated genotyping system for analysis of HIV-1 and other microbial sequences.

Authors:  Tulio de Oliveira; Koen Deforche; Sharon Cassol; Mika Salminen; Dimitris Paraskevis; Chris Seebregts; Joe Snoeck; Estrelita Janse van Rensburg; Annemarie M J Wensing; David A van de Vijver; Charles A Boucher; Ricardo Camacho; Anne-Mieke Vandamme
Journal:  Bioinformatics       Date:  2005-08-02       Impact factor: 6.937

4.  Identification of two HIV type 1 circulating recombinant forms in Brazil.

Authors:  Dercy José De Sá Filho; M Cecilia A Sucupira; Marcos M Caseiro; Marcos M Casiero; Ester C Sabino; Ricardo Sobhie Diaz; Luiz Mario Janini
Journal:  AIDS Res Hum Retroviruses       Date:  2006-01       Impact factor: 2.205

5.  Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.

Authors:  José Antonio Sá-Ferreira; Patrícia Alvarez Brindeiro; Saada Chequer-Fernandez; Amilcar Tanuri; Mariza Gonçalves Morgado
Journal:  Transfusion       Date:  2007-01       Impact factor: 3.157

6.  High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.

Authors:  Florence Doualla-Bell; Ava Avalos; Bluma Brenner; Tendani Gaolathe; Madisa Mine; Simani Gaseitsiwe; Maureen Oliveira; Daniella Moisi; Ndwapi Ndwapi; Howard Moffat; Max Essex; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

7.  Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.

Authors:  Joris Hemelaar; Eleanor Gouws; Peter D Ghys; Saladin Osmanov
Journal:  AIDS       Date:  2006-10-24       Impact factor: 4.177

8.  Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil.

Authors:  Claudia C Barreto; Anna Nishyia; Luciano V Araújo; João E Ferreira; Michael P Busch; Ester C Sabino
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

9.  Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

Authors:  A K Iversen; R W Shafer; K Wehrly; M A Winters; J I Mullins; B Chesebro; T C Merigan
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

10.  Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.

Authors:  T Shirasaka; M F Kavlick; T Ueno; W Y Gao; E Kojima; M L Alcaide; S Chokekijchai; B M Roy; E Arnold; R Yarchoan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205
View more
  3 in total

1.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

2.  Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008).

Authors:  Jorge L Martinez-Cajas; Nitika P Pai; Marina B Klein; Mark A Wainberg
Journal:  J Int AIDS Soc       Date:  2009-06-30       Impact factor: 5.396

3.  HIV Genetic Diversity and Drug Resistance.

Authors:  André F Santos; Marcelo A Soares
Journal:  Viruses       Date:  2010-02-02       Impact factor: 5.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.